 |
|
|
Divisions Hematology & Oncology Laura Hutchins, M.D. Clinical Programs and Facilities The Division of Hematology/Oncology provides diagnosis and therapy for all malignancies and non-neoplastic conditions such as anemia, coagulation and immunodeficiency problems. The major focus of the Division is the treatment of malignant diseases, using standard dose chemotherapy, and biologic response-modifying agents. Most diagnostic and therapeutic approaches are performed according to specific research protocols. 
Solid Tumor programs have recently expanded and multidisciplinary clinics are offered in gastrointestinal malignancies, lung carcinoma, breast cancer and melanoma. Clinical research efforts are organized along these working groups in these specific tumor areas. Research Programs and Facilities The major focus of clinical and laboratory investigation is on B cell neoplasia, especially multiple myeloma and related disorders. The work includes research to identify the tumor stem cell of multiple myeloma and studies of the cytokine network involved in myeloma growth and disease manifestation. Mechanisms of growth control exerted by various host cells are also being studied such as natural killer and cytoxic T cells. Other research areas address the regulation of normal hemopoiesis and protection of normal tissue from cytotoxic drug damage. Laboratory research has also been initiated to use viral vectors for the transduction of genes into normal and tumor cells. University of Arkansas for Medical
Sciences Hematology/Oncology Administrative
offices: 1-501-686-8511
|
